A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria
Clinical trial NCT07005713 · COMPLETED
Trial details
- NCT number
- NCT07005713
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-19
- Primary completion
- 2026-04-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.